Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 3 March 2006:
Vol. 311. no. 5765, p. 1215
DOI: 10.1126/science.311.5765.1215c

Editors' Choice: Highlights of the recent literature

Pro-opiomelanocortin (POMC) undergoes posttranslational processing to yield a bunch of physiologically active peptides. In the hypothalamus, POMC is a precursor to the melanocortins (alpha-MSH, beta-MSH, and -MSH). Humans and mice lacking functional POMC or MC4R (melanocortin-4 receptor, which is activated by alpha- and beta-MSH) become obese; because rodents cannot synthesize beta-MSH, this effect has been attributed to alpha-MSH. Biebermann et al. find that a severely obese child has a mutant form of beta-MSH in which a cysteine has been substituted for a tyrosine, a mutation also present in obese family members. Restriction enzyme analysis of 722 obese and 1270 non-obese children and adolescents uncovered the mutation in 2 obese individuals and none of the controls. Lee et al. discovered the same beta-MSH variant in 5 of 538 unrelated severely obese children and 1 of 300 non-obese adults and found that the mutation segregated with obesity in family members. Both groups observe that the mutant form showed substantially reduced binding to human MC4R and conclude that, unlike in rodents, beta-MSH is important in regulating energy balance and body weight in humans. -- EMA

Cell Metab. 3, 141; 135 (2006).






To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)